	Breast density classification using frequency-based features in microwave imaging. Sci Rep Taghipour-Gorjikolaie M, Khalesi B, Khalid B, Ghavami N, Badia M, Ghavami M, Tiberi G. PMID: 41310083 [PubMed - as supplied by publisher]
	Association of neutrophil percentage-to-albumin ratio with distant metastasis and survival outcomes in breast cancer patients: a retrospective and prospective cohort study. Sci Rep Liu Y, Luo R, Wu Z, Zhang W, Liang C, Liu Z, Zhao H. PMID: 41310002 [PubMed - as supplied by publisher]
	PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial. Eur J Nucl Med Mol Imaging Manley M, Nader-Marta G, Ozturk AA, Kassas M, Rothé F, Taraji L, Sotiriou C, Wimana Z, Salgado R, Flamen P, Gebhart G. PMID: 41309999 [PubMed - as supplied by publisher]
	A study on the value of ultrasound strain elastography-based radiomics nomogram in the differential diagnosis of breast masses. Sci Rep Zhu Y, Dou Y, Hu Q, Wang H. PMID: 41309973 [PubMed - as supplied by publisher]
	A Benchmark for Breast Cancer Screening and Diagnosis in Mammogram Visual Question Answering. Nat Commun Zhu J, Huang F, Luo Q, Chen H. PMID: 41309622 [PubMed - as supplied by publisher]
	A prospective trial for breast cancer diagnosis by canine odorology. Nat Commun Tardivon A, Mesurolle B, Dureau S, Poncelet E, Dravet F, Langer A, El Bejjani MR, Alran S, Deluche E, Savignoni A, Kadi A, Bauër P, Gilbert C, Leemans M, Fromantin I. PMID: 41309562 [PubMed - indexed for MEDLINE]
	Genitourinary syndrome of menopause induced by breast cancer treatments: a randomised clinical trial protocol comparing multimodal pelvic floor physiotherapy and fractional CO(2) laser therapy (PILME study). BMJ Open Torres-Lacomba M, Hernández-Iglesias CM, Del Valle-Rubido C, Navarro-Brazález B, Rangel-de la Mata P, Lorenzo-Gallego L, Sánchez-Sánchez B, Salvador-Osuna M, Lázaro-Carrasco de la Fuente J. PMID: 41309480 [PubMed - indexed for MEDLINE]
	Identification of lncRNA ZNF252P-AS1 as a novel diagnostic and prognostic biomarker for breast cancer patients: An integrated bioinformatics and experimental analysis. Clin Chim Acta El-Ashmawy NE, Abo-Saif MA, Hamouda SM, Khedr EG. PMID: 41308720 [PubMed - as supplied by publisher]
	The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus. Lancet Oncol Pfob A, Pinker K, Vaz-Luis I, Di Meglio A, Cardoso MJ, Curigliano G, Gentilini OD, Gruber G, Hauser N, Heil J, Kaidar-Person O, Knauer M, Lee HB, Lee SB, Loi S, Mannhart M, Mastora S, Meattini I, Di Micco R, Noske A, Peccatori FA, Poulakaki F, Reinisch M, Rubio IT, Swanton C, Tausch C, Vrancken Peeters MJ, Yu JH, Weber WP, Zerbe N, Poortmans P, Denkert C, Mann R, Delaloge S, Dubsky P, Toolbox 3 Consortium. PMID: 41308690 [PubMed - indexed for MEDLINE]
	Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials. Lancet Oncol Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, Denkert C, Bagnardi V, Pala L, Fasching PA, Schneeweiss A, Lück HJ, Viale G, De Pas T, van Mackelenbergh M, Huober J, Müller V, Link T, Karn T, Reinisch M, Marmé F, Bjelic-Radisic V, Schem C, Hartkopf A, Stickeler E, Hanusch C, Blohmer JU, Fehm T, Rhiem K, Gelber R, Loibl S. PMID: 41308675 [PubMed - indexed for MEDLINE]
	Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial. Lancet Oncol Yuan J, Bi XW, Hua X, Huang H, Cai L, Zhao L, Chen QJ, Chen XX, Wang XL, Lin Y, Zhang AQ, Zhong YY, Xu F, Huang JJ, An X, Shi YX, Wang X, Wang SS, Xue C, Yuan ZY. PMID: 41308674 [PubMed - indexed for MEDLINE]
	Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial. Lancet Oncol Li H, Liu J, Ouyang Q, Wang S, Liu Y, Teng Y, Wang X, Cheng J, Tong Z, Sun T, Yan M, Zhou X, Li F, Nie J, Shao ZM, Ye C, Wang Y, Wu X, Li Z, Wu Y, Xiong H, Li H, Gan L, Niu Z, Zhang J, Zhang Q, Pan Y, Wu X, Zhang Y, Xie W, Xiao Y, Gao J, Zhao H, Yin Y, Qian Z, Sun S, Zhang H, Wang K, Lu J, Li Y, Wang X, Yang X, Wang Y, Wang Q, Song E. PMID: 41308673 [PubMed - indexed for MEDLINE]
	Synthesis and in vitro studies of doxorubicin-Cu(2+) prodrug and glucose oxidase co-encapsulated oxidized hyaluronic acid/carboxymethyl chitosan hydrogels on breast cancer cell line 4T1. Carbohydr Res Li S, Bian H, Tan Y, Li Y, Shou D, Jiang T, Kong Y. PMID: 41308478 [PubMed - as supplied by publisher]
	Beam me later: Prepectoral vs subpectoral breast reconstruction before postmastectomy radiotherapy - A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg Størling R, Johansen R, Lilja C, Damsgaard TE. PMID: 41308380 [PubMed - as supplied by publisher]
	Effect of glucagon-like peptide-1 agonists on deep inferior epigastric perforator flap breast reconstruction outcomes in obese patients: A study of 5618 patients. J Plast Reconstr Aesthet Surg Sidhu AS, Chopra AA, Ahmed S, Corpuz GS, Towfighi PN, Danforth RM, Lester ME, Hassanein AH. PMID: 41308379 [PubMed - as supplied by publisher]
	Reduced Manual Performance in Right-Handed Women With Breast Cancer. Percept Mot Skills Ferjaoui F, Ben Ahmed S, Belaid I, Touinsi M, Dahmen R. PMID: 41308179 [PubMed - as supplied by publisher]
	Comparing relative dose intensity of weekly nab-paclitaxel regimens in early breast cancer: A retrospective study at a large academic outpatient cancer center. J Oncol Pharm Pract Gee-Rodriguez K, Yun J, Duong A, Indorf A. PMID: 41308080 [PubMed - as supplied by publisher]
	Genetic and immune regulatory links between inflammatory bowel disease and breast cancer involving the JAK STAT PD L1 axis. Discov Oncol Zeng L, Zhang J, Liu X, Yang X, Nie Q. PMID: 41307839 [PubMed - as supplied by publisher]
	Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer. Breast Cancer Res Treat Zelizer S, Gallagher GB, Gonen M, Dang C, Modi S, Chandarlapaty S, Drago JZ. PMID: 41307769 [PubMed - indexed for MEDLINE]
	Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast. Breast Cancer Res Treat Kaur M, Quirarte A, Vertido A, Torosian T, Li TM, Mouabbi JA, Mukhtar RA. PMID: 41307765 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 212285

Page 1 of 10615



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy